top of page

MDCG Guidance for NBs, importers, & distributors: QMS certification for relabelling & repackaging

Writer: Sharan MuruganSharan Murugan

The MDCG Guidance provides an overview of activities, requirements, auditing, surveillance and changes and minimum content of the Certificates issued by a notified body.

This guidance document is mainly focused on activities performed by notified bodies, providing also clarification on the quality management system they are expected to assess.


This guidance is intended to provide assistance to notified bodies to implement requirements established by MDR and IVDR with regard to certification activities to be carried out according to Article 16(4), attesting that the quality management system of the distributor or importer carrying out any of the activities mentioned in points (a) and (b) of Article 16(2) complies with the relevant requirements.


This guidance is also addressed to distributors and importers in respect to their quality management system to be certified by a notified body.


The quality management system should govern the structure, responsibilities, procedures, processes and management of resources required to implement the principles and actions necessary to achieve compliance with the provisions of Article 16(3) of the MDR / IVDR.


To view the points that is expected to cover and address from quality management system is detailed in the guidance.

Comentários


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page